‹ All Posts
SFP RESEARCH

20th Aug 2025 · SEBI-Registered Analyst

Dr. Reddy's Laboratories

Leading pharmaceutical firm with a strong global generics presence, especially in the US and Russia. Regulatory headwinds occasionally affect export potential, but domestic growth is robust. Focused pipeline in biosimilars and specialty drugs aids long-term prospects. Margin volatility possible due to price competition and R&D investments.

#WatchOutFor#FundamentalViews#TechnicalViews#Miscellaneous#EquityResearch
583 likes·43 comments